The differential effect of injecting estradiol-17beta, testosterone, and hydrocortisone during the immune adaptive period on the fertility of female mice.

Abstract

Female mice injected with estradiol-17beta (E2) and testosterone during the immune adaptive period are infertile as adults. Study 1 examined the effect of the day of injection of E2 and testosterone on the incidence of infertility in two strains of mice. Study 2 examined the effect of hydrocortisone on E2-induced infertility. Study 1: Neonatal (C57BL/6J x A/J)F1 B6A and (C3H/HeJ x 129J)F1 C31 female mice were injected from 0 to 3 and from 3 to 6 days of age with either 20 microg E2 or 20 microg testosterone. Animals were tested for fertility by mating with fertile males. Study 2: Neonatal B6A females were injected with 20 microg E2 with/without 1000 microg hydrocortisone on days 1, 3, 5, 7, and 10. At adulthood, ovaries were examined for the presence of corpora lutea (CLs). Study 1: The incidence of E2-induced infertility in adult B6A and C31 females decreased over three consecutive matings. In contrast, the incidence of testosterone-induced infertility in adult B6A and C31 females increased. E2 caused the highest incidence of infertility in C31 females when injected prior to 3 days of age. In B6A mice, E2 caused the highest incidence of infertility when injected after 3 days of age. Study 2: When hydrocortisone was injected with E2, 90% of the B6A females had ovaries with CLs at 100 days of age. Without hydrocortisone, only 16% of the B6A females injected with E2 had ovaries with CLs. Study 1: The incidence of infertility caused by injections of E2 is dependent on the strain of mice and the day(s) injected. The incidence of infertility caused by injections of testosterone is independent of the strain of mice. Study 2: Hydrocortisone prevents E2-induced infertility. It is proposed that injections of E2 during the immune adaptive period alter T-cell maturation, which contributes to E2-induced infertility.